Skip to content

Device feasibility and evaluation study in a primary health setting

Evaluation of Swaasa Artificial Intelligence (AI) platform for lung health assessment in a primary health care setting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035096
Enrollment
2500
Registered
2021-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

None listed

Sponsors

Salcit Technologies Private Limited
Lead Sponsor
Ministry of electronics and information technology TIDE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Male and female participants with 18 years of age and over. Patients presenting with respiratory complaints. Will have gone through the information sheet and provided informed consent.

Exclusion criteria

Exclusion criteria: Patients less than 18 years of age. Patients who are already undergoing treatment for respiratory complaints, and who are discharged from hospitals in less than 4 weeks. Patients who used inhalers 12-14 hours prior to the assessments must be excluded. (The effect of inhalers lasts for 12-14 hours). Pregnant women. Subjects in acute exacerbation/ severe breathlessness/ recent myocardial infarction or pulmonary embolism (within 4-6 weeks)/ recent eye or abdominal or brain surgery.

Design outcomes

Primary

MeasureTime frame
Evaluate the effectiveness of Swaasa AI platform in detecting respiratory problems in a primary health care setting. For calculation of accuracy measures, clinical diagnosis is considered as a reference standard. The primary measures of diagnostic accuracy that will be used are sensitivity, specificity, positive and negative predictive values. 95% CIs around these parameters will be calculated using the method of clopper-pearson.Timepoint: 7 months

Secondary

MeasureTime frame
Feasibility of the device demonstrated based on parameters (a) Safety - Evaluate product safety in determining technical and market feasibility of the product. The safety can be evaluated based on guidelines ISO 14971. (b) Customer usage ââ?¬â?? Evaluation of usability or user-friendliness of the product or service.Timepoint: 7 months

Countries

India

Contacts

Public ContactNarayana Rao Sripada

Dept of Community Medicine, AMC

beti.haritha@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026